MEDICINOVA, INC. Cash and Cash Equivalents
MEDICINOVA, INC. (MNOV) had Cash and Cash Equivalents of $25.42 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $25.42M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $27.33M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $30.81M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $32.56M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $25.42M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $27.33M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $30.81M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $32.56M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $34.26M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $36.57M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $40.36M 10-K · filed 2026-03-10 |
| 2024-09-30 | $42.28M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $44.34M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $47.14M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $51.00M 10-K · filed 2025-02-19 |
| 2023-09-30 | $51.51M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $52.88M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $55.26M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $18.51M 10-K · filed 2024-02-15 |
| 2022-09-30 | $52.51M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $65.23M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $67.70M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $71.43M 10-K/A · filed 2023-03-28 |
| 2021-09-30 | $75.03M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $77.79M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $76.30M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $60.04M 10-K · filed 2022-02-16 |
| 2020-09-30 | $61.66M 10-Q · filed 2020-10-26 |
| 2020-06-30 | $60.44M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $61.33M 10-Q · filed 2020-04-23 |
| 2019-12-31 | $63.79M 10-K · filed 2021-02-19 |
| 2019-09-30 | $62.87M 10-Q · filed 2019-10-24 |
| 2019-06-30 | $61.74M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $63.21M 10-Q · filed 2019-04-25 |
| 2018-12-31 | $62.31M 10-K · filed 2020-02-13 |
| 2018-09-30 | $62.44M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $64.16M 10-Q · filed 2019-07-25 |
| 2018-03-31 | $62.94M 10-Q · filed 2019-04-25 |
| 2017-12-31 | $27.99M 10-Q · filed 2019-07-25 |
| 2017-09-30 | $24.54M 10-Q · filed 2018-10-25 |
| 2017-06-30 | $22.89M 10-Q · filed 2018-07-23 |
| 2017-03-31 | $21.64M 10-Q · filed 2018-04-25 |
| 2016-12-31 | $24.12M 10-K · filed 2019-02-13 |
| 2016-09-30 | $24.97M 10-Q · filed 2017-10-23 |
| 2016-06-30 | $26.57M 10-Q · filed 2017-07-26 |
| 2016-03-31 | $27.62M 10-Q · filed 2017-04-26 |
| 2015-12-31 | $22.08M 10-K · filed 2019-02-13 |
| 2015-09-30 | $23.61M 10-Q · filed 2016-10-25 |
| 2015-06-30 | $8.58M 10-Q · filed 2016-07-26 |
| 2015-03-31 | $9.07M 10-Q · filed 2016-04-27 |
| 2014-12-31 | $11.67M 10-K · filed 2018-02-13 |
| 2014-09-30 | $11.94M 10-Q · filed 2015-10-29 |
| 2014-06-30 | $13.50M 10-Q · filed 2015-07-30 |
| 2014-03-31 | $14.78M 10-Q · filed 2015-05-11 |
| 2013-12-31 | $6.70M 10-K · filed 2017-02-14 |
| 2013-09-30 | $10.66M 10-Q · filed 2014-11-13 |
| 2013-06-30 | $12.02M 10-Q · filed 2014-08-13 |
| 2013-03-31 | $3.03M 10-Q · filed 2014-05-08 |
| 2012-12-31 | $4.01M 10-K · filed 2015-03-12 |
| 2012-09-30 | $5.74M 10-Q · filed 2013-11-07 |
| 2012-06-30 | $7.26M 10-Q · filed 2013-08-08 |
| 2012-03-31 | $11.01M 10-Q · filed 2013-05-08 |
| 2011-12-31 | $15.09M 10-K · filed 2014-03-27 |
| 2011-09-30 | $8.74M 10-Q · filed 2012-11-08 |
| 2011-06-30 | $11.92M 10-Q · filed 2012-08-09 |
| 2011-03-31 | $31.38M 10-Q · filed 2012-05-10 |
| 2010-12-31 | $28.25M 10-K · filed 2013-03-28 |
| 2010-09-30 | $31.16M 10-Q · filed 2011-11-14 |
| 2010-06-30 | $25.36M 10-Q · filed 2011-08-15 |
| 2009-12-31 | $19.24M 10-K · filed 2012-03-29 |
| 2008-12-31 | $19.30M 10-K · filed 2012-03-29 |
| 2000-12-31 | $0.00 10-Q · filed 2011-11-14 |
| 2000-09-25 | $0.00 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |